Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)
Clinical Trial Grant
Awarded By
Ipsen Biopharmaceuticals, Inc.
Start Date
December 13, 2016
End Date
May 31, 2024
Awarded By
Ipsen Biopharmaceuticals, Inc.
Start Date
December 13, 2016
End Date
May 31, 2024